Article
Lamivudine can exert a modest antiviral effect against human immunodeficiency virus type 1 containing the M184V mutation.
Antimicrobial agents and chemotherapy - 1 Feb 2003
Quan Yudong, Brenner Bluma G, Oliveira Maureen, Wainberg Mark A
Abstract excerpt
The M184V mutation in human immunodeficiency virus (HIV) reverse transcriptase is associated with high-level resistance to both (-)2',3'-dideoxy-3'-thiacytidine (3TC) and (-)2',3'-dideoxy-5-fluoro-3'-thiacytidine as well as low-level resistance to 2',3'-dideoxyinosine, 2',3'-dideoxycytidine, and abacavir. This mutation is also associated with diminished HIV replicative fitness as well as several functional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
